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Abstract. A method to prepare synthetically important 3,5-
disubstituted phenol derivatives that relies on the sequential 
gold(I)-catalyzed dehydrogenative cycloisomerization of 1,4-
enyne esters in the presence of 2,3-dichloro-5,6-
dicyanobenzoquinone (DDQ) or N-fluorobenzenesulfonimide 
(NFSI) is described. The synthetic versatility of the 
methodology was exemplified by a gram-scale reaction of one 
example, the ease to realize subsequent functional 
transformations of an adduct, and the application of the 
method to the synthesis of the bioactive molecule LUF5771. 
Keywords: 1,4-enyne esters; 3,5-disubstituted phenols; 
dehydrogenative cycloisomerization; gold; homogenous 
catalysis  
Introduction 
Phenols are important core structures and precursors 
for the construction of a wide variety of bioactive 
natural products, pharmaceutical compounds and 
polymers.[1–5] Representative of this are members of 
the family with a 3,5-disubstitution pattern that are 
found in a myriad of pharmacologically interesting 
compounds such as those illustrated in Figure 1.[2–5] 
For this reason, the development of synthetic 
approaches to construct 3,5-disubstituted phenols with 
selective control of substitution patterns efficiently is 
of considerable current interest. The regiospecific 
preparation of 3,5-disubstituted phenols via traditional 
electrophilic aromatic substitution of phenols, 
however, can be synthetically challenging due to the 
well-known strong o,p-directing effect of the hydroxyl 
functional group. Consequently, this has led to the 
establishment of a number of elegant synthetic 
methodologies in recent years.[6–11] Included in this 
have been synthetic approaches that have relied on the 
oxidative dehydrogenation,[6] base-promoted 
eliminative aromatization,[7] [3+3] annulation,[8] ring- 
closing olefin metathesis cascade,[9] and gold(I)- 
 
Figure 1. Selected examples of bioactive 3,5-disubstituted 
phenol derivatives.[2–5] 
catalyzed annulation[10] of nonaromatic precursors. 
The transition-metal catalyzed template assisted C–H 
bond meta-functionalization of phenols has also been 
recently disclosed.[11] Despite these advances, there 
remains a need to realize new synthetic methods for 
the efficient preparation of 3,5-disubstituted phenols 
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Gold-mediated cycloisomerization of 1,n-enynes 
and 1,n-enyne esters has become one of the most atom-
economical and versatile synthetic strategies to rapidly 
increase molecular complexity in a single 
operation.[12–18] A recent notable example is the 
gold(I)-catalyzed cycloisomerization of 1,4-enyne 
acetates to bicyclo[3.1.0]hexenes (Scheme 1a).[15] 
Following this pioneering work, we reported the 
gold(I)-catalyzed tandem 1,3-acyloxy 
migration/double cyclopropanation of 1-ene-4,9-diyne 
and 1-ene-4,10-diyne esters to the architecturally 
challenging tetracyclodecenes and 
tetracycloundecenes via the bicyclic intermediate 
(Scheme 1a).[16] Inspired by these studies and as part 
of ongoing efforts in the field,[17] we were drawn to the 
potential reactivity of 1,4-enyne esters in the presence 
of an oxidant such as DDQ or NFSI (Scheme 1b).[18] 
We reasoned that such bicyclo[3.1.0]hexene adducts 
generated from gold(I)-catalyzed cycloisomerization 
of the substrate might be susceptible to a 
dehydrogenative/ring-opening pathway due to the 
oxidant to provide the 3,5-disubstituted aromatic ring 
system. Herein, we describe the details of this 
chemistry that provides an expedient and 
regioselective approach to the synthetically important 
phenolic ester derivative in good to excellent yields. 
The synthetic versatility of the methodology by 
demonstrating the ability to carry out a gram-scale 
reaction of one example and the ease to further 
functionalize the adduct along with the preparation of 
the LH-receptor antagonist LUF5771 in two steps is 
also presented.[2] 
 
Scheme 1. Gold(I)-catalyzed reactivities of 1,4-enyne esters 
Results and Discussion 
The 1,4-enyne esters studied in this work were 
prepared from the corresponding aldehyde or 
carboxylic acid starting materials in three to four steps 
following literature procedures.[19] By choosing 1a as 
the model substrate, we commenced our studies by 
examining the gold-catalyzed dehydrogenative 
rearrangement of the 1,4-enyne ester in the presence of 
an oxidant to establish the optimum reaction 
conditions (Table 1). This initially revealed that the 
anticipated phenol derivative 4a could be obtained in 
82% yield on treating the substrate with 2 mol % of 
gold(I) phosphine catalyst A[20a] and NFSI (2 equiv) 
in1,2-dichloroethane at 80 °C for 12 h (entry 1). More- 
Table 1. Optimization of the reaction conditions[a] 
 





1 A NFSI 12 - 82 
2 A -b 24 99 - 
3 A SelectFluor 120 - 66 
4 A DDQ 4 - 99 
5[c] A DDQ 120 - 87 
6[d] A DDQ 4 - 99 
7[d,e] A DDQ 4 - 97 
8[d] B DDQ 3 - 85 
9[d] C DDQ 16 - 97 
10[d] PPh3AuNTf2 DDQ 3 - 80 
11[d] D DDQ 24 - 82 
[a]All reactions were performed using 0.3 mmol of 1a, 2 mol % 
of gold(I) or gold(III) catalyst and 0.6 mmol of oxidant in 
(CH2Cl)2 at 80 °C. [b]Reaction carried out in the absence of 
an oxidant. [c]Reaction carried out at room temperature. 
[d]Reaction performed with 0.36 mmol of DDQ. [e]Reaction 
performed in toluene. 
over, a control experiment in the absence of NFSI was 
found to give the bicyclo[3.1.0]hexene adduct 2a in 
99% yield (entry 2). These promising results 
encouraged us to next examine other oxidants, which 
showed replacing NFSI with SelectFluor led to a lower 
product yield of 66% and the need of a reaction time 
of 5 days (entry 3). Changing the oxidant to DDQ, on 
the other hand, was found to increase the yield of 4a to 
99% after 4 h (entry 4). Repeating these reaction 
conditions at room temperature proceeded slowly and 
required a reaction time of 5 days to furnish a product 
yield of 87% (entry 5). Our investigations 
subsequently found a product yield 99% could also be 
achieved under the reaction conditions described in 
entry 4 and at a lower loading of DDQ of 1.2 equiv 
(entry 6). Under these latter conditions, a comparable 
product yield of 97% was obtained when the reaction 
was conducted in toluene instead of 1,2-
dichloroethane as the solvent (entry 7). Likewise, 
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Au(I) complex B,[20b] NHC−Au(I) (NHC = N-
heterocyclic carbene) complex C,[20c] Ph3PAuNTf2[20c] 
or gold(III) complex D[20d] in place of A as the catalyst 
provided 4a in 80−97% yield (entries 8−11). On the 
basis of the above results, reaction of 1a in the 
presence of 2 mol % of Au(I) complex A as the catalyst 
and 1.2 equiv of DDQ (Method A) or 2 equiv of NFSI 
(Method B) as the oxidant in 1,2-dichloroethane at 80 
°C for 4 or 12 h were deemed to provide the optimum 
conditions. 
With the optimal conditions in hand, we next 
evaluated the generality of the present procedure with 
a series of 1,4-enyne esters, and the results are 
summarized in Scheme 2. Overall, the Au(I) complex 
A-catalyzed reaction conditions were found to be 
broad, providing a diverse set of 3,5-disubstituted 
phenol derivatives containing a variety of substitution 
patterns in 46–99% yield from the corresponding 
substrates 1a–y. Under the conditions of Method A, 
the introduction of an acyl (1b) instead of a p-
nitrobenzoyl (PNB) migrating group was found to 
proceed well, producing the corresponding 3,5-
disubstituted phenol 4b in 74% yield. Similarly, the 
reaction of substrates bearing a phenyl ether (1c), 
malonate (1e) and a tertiary sulfonamide (1f) group at 
the R3 position were shown to give the corresponding 
3,5-disubstituted phenols 4c and 4e–f in 72–97% yield. 
The dehydrogenative rearrangement of 1d with a 
pendant methyl carbonate group was found to proceed 
best under the conditions of Method B, affording 4d as 
well as 4a as a byproduct in respective yields of 46 and 
37%. The presence of an electron-donating (1g,l and 
1m) or electron-withdrawing (1h–k) substituent on the 
phenyl group at the R2 position of the substrate was 
also found to have no appreciable effect on the 
outcome of the reaction. In these experiments, the 
corresponding phenol products 4g–m were obtained in 
excellent yields of 84–98% under the conditions of 
Method A. Similarly, substrates containing a naphthyl 
(1n–o), or indolyl (1p) motif at the same position were 
well tolerated, furnishing the corresponding phenol 
derivatives 4n–p in 62-99% yield. Under the reaction 
conditions of Method B, the diphenyl substituted 
substrate 1q gave the corresponding phenolic ester 
adduct 4q in 68% yield. Gratifyingly, the starting 
esters bearing an aliphatic substituent at both the R2 
and R3 positions, as in 1r–w, were also converted to 
the corresponding phenols 4r–w in 60-77% yield using 
either Method A or B albeit requiring longer reaction 
times. Due to the importance of terphenyls and their 
derivatives in the ﬁelds of optical and conductive 
materials, as well as a wide range of biological 
applications,[2,21,22] the symmetrical 1,4-enyne ester 1x 
was next examined. Under the reaction conditions of 
Method A at a catalyst loading of 4 mol % and 2.4 
equiv of DDQ, this gave the expected terphenyl 4x in 
53% yield. The 1,4-enyne ester 1y, which was 
prepared from the bioactive natural product betulin, 
was additionally shown to undergo dehydrogenative 
cycloisomerization to afford 4y in an excellent yield of 
94%. 
 
Scheme 2. Gold(I)-catalyzed dehydrogenative 
cycloisomerization of 1,4-enyne esters 1b–y. All reaction 
performed following: Method A: reaction performed with 1 
(0.3 mmol), Au(I) complex A (2 mol%) and DDQ (0.36 
mmol) in (CH2Cl)2 at 80 °C; or Method B: reaction 
performed with 1 (0.3 mmol), Au(I) complex A (2 mol%) 
and NFSI (0.6 mmol) in (CH2Cl)2 at 80 °C. Values in 
parentheses denote isolated product yields and reaction 
times. [a]Compound 4a was isolated in 37% yield. 
[b]Reaction performed 4 mol % of Au(I) complex A and with 
2.4 equiv of DDQ. 
To demonstrate the scalability and practicality of 
the present protocol, a gram-scale reaction of 1a (4 
mmol, 1.34 g) was carried out in the presence of 1 mol 




























A: 4c, R = Ph  (72%, 6 h)
B: 4d, R = Ac (46%, 12 h)[a]
A: 4g, R = Me (98%, 4 h)
A: 4h, R = Br  (96%, 8 h)




A: 4j, R = Br (92%, 10 h)
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A: 4v, R = Bn  (64%, 48 h)





described in Scheme 3, this provided 4a in 96% yield 
(1.28 g). Accordingly, subjecting the adduct to 5 mol% 
benzoyl peroxide (BPO) and to N-bromosuccinimide 
(NBS, 1.1 equiv) in carbon tetrachloride at 80 °C for 
15 h afforded the benzylic bromide 5 (1.05 g) in 66% 
yield. Subsequently, the synthetic versatility of 5 was 
demonstrated by its successfully conversion to the 
corresponding 3,5-disubstituted phenols with a range 
of functional groups (Scheme 3). By applying 
corresponding nucleophilic substitution reaction 
conditions, this included compounds with an azide (6), 
nitrate (7), selenocyanate (8) and thioether (9) motif in 
yields of 65–97%. 
 
Scheme 3. Scale-up experiments and synthetic 
transformations. 
The synthetic application of the methodology was 
next demonstrated by the transformation of 4q to the 
O-terphenylcarbamate LUF5771, a novel inhibitor of 
the human luteinizing hormone receptor.[2,6b,g,8c] As 
shown in Scheme 4, methanolysis of the 3,5-diphenyl-
substituted substrate was achieved by subjecting it to 
K2CO3 in methanol at room temperature for 2 h. This 
was followed by treatment of the resultant crude 
mixture with cyclopentylisocyanate to furnish 
LUF5771 in 95% yield over two steps. This is 
comparable product yields obtained by previously 
reported synthetic methods to prepare the LH-receptor 
antagonist from a cyclic or acyclic precursor.[2,6b,8c] 
 
Scheme 4. Synthesis of the LH-Receptor antagonist 
LUF5771.[2,6b,8c] 
To gain an insight into the reaction mechanism, a 
number of control experiments were performed (Table 
2 and Scheme 5). Our initial premise reasoned that the 
bicyclo[3.1.0]hexane adduct obtained from the gold 
catalysis step might be susceptible to a ring-
opening/dehydrogenation process in the presence of an 
oxidant. With this mind, we first examined the reaction 
of 2a in the presence and absence of the gold(I) 
catalyst A (2 mol %), 1.2 equiv of DDQ and (2,2,6,6-
tetramethylpiperidin-1-yl)oxyl (TEMPO, 2 equiv) 
under the conditions described in Table 2, entries 1 and 
4. These tests was found to result in no reaction and, 
in both cases, the recovery of the starting material in 
99% yield. Initially, this led us to consider a reaction 
mechanism involving the possible formation of a 
radical species as well as the bicyclic adduct as a key 
intermediate.[23] This was further supported by 
performing the reaction again for a third time in the 
absence of TEMPO and obtaining 4a in 99% yield 
within 4 h (entry 2). Intriguingly, the transformation 
proceeded very slowly on repeating the reaction for a 
fourth time in the absence of gold catalyst A, requiring 
5 days to furnish the product in 97% yield (entry 5). A 
similar outcome was observed when these latter set of 
two control experiments with 2a was conducted with 
NFSI as the oxidant (entries 3 and 6). The possibility 
of an alternative competing pathway involving a 
hydride abstraction step, however, could not be ruled 
out based on findings obtained from control reactions 
of 2a with BF3Et2O or CuI in place of A as the 
catalyst.[24] Under the reaction conditions detailed in 
entries 7 and 8, these experiments gave the phenolic 
ester product in respective yields of 98 and 82%. 
Consistent with this are our findings in a control 
experiment treating 2a to the conditions described in 
Scheme 5, which gave compound 10 in 21% yield and 
Table 2. Control experiments with 2a[a] 
 
Entry Catalyst [O] Reaction Time [h] Yield [%][b] 
1[c] A DDQ 24 -[d] 
2 A DDQ 4 99 
3 A NFSI 12 83 
4[c] - DDQ 24 -[d] 
5 - DDQ 120 97 
6 - NFSI 72 81 
7 BF3Et2O DDQ 6 98 
8 CuI DDQ 24 82 
[a]All reactions were performed using 0.2 mmol of 2a, in the 
presence or absence of 2 mol % of catalyst, DDQ (0.24 
mmol) or NFSI (0.4 mmol) in (CH2Cl)2 at 80 °C. [b]Isolated 
product yield. [c]Reaction conducted in the presence of 
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9,  95% yield
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as a 1.1:1 mixture of regioisomers along with the 
substrate and 4a in 31 and 19% yield, respectively.[25,26] 
 
Scheme 5. Control experiment with 2a in the presence of 
TMSN3. 
On the basis of the above observations, a tentative 
mechanism for the present Au(I)-catalyzed 1,4-enyne 
ester dehydrogenative cycloisomerization reaction in 
the presence of DDQ is illustrated in Scheme 6. With 
1a as a representative example, this initially involves 
Au(I)-catalyzed tandem [3,3]-rearrangement/ 
cyclopropanation to produce the bicyclo[3.1.0]hexene 
2a.[15,16] At this juncture, it is thought that the 
transformation of the bicyclic adduct to the phenolic 
ester product could proceed through possible 
competitive pathways a or b. While highly speculative, 
pathway a might begin with oxidation of the gold(I) 
catalyst by two molecules of DDQ to provide the 
gold(III) species EO.[27,28] As a consequence, this 
could lead to two molecules of the bicyclic adduct to 
undergo a hydrogen atom transfer (HAT) process with 
the in situ formed Au(III) complex to afford the  
 
Scheme 6. Proposed mechanism for Au(I)-catalyzed 
dehydrogenative cycloisomerization of 1,4-enyne esters in 
the presence of DDQ represented by 1a. 
carboradical species Ia.[23] The gold(III) adduct EOH 
also formed in this step may trigger further oxidation 
of Ia via a single-electron transfer (SET) event. This 
would give the allylic cation IIa and regenerate the 
Au(I) catalyst along with the two equivalents of 
DDQH–, which would yield DDQH2 on protonation. 
Alternatively, as shown in pathway b in Scheme 6, the 
bicyclic carbocation intermediate could be generated 
as a result of hydride abstraction of 2a by DDQ.[24] The 
oxidizing ability of the quinone may be enhanced by 
the coordination of the Lewis acid to the oxygen center 
of the oxidant. Protodeauration of the ensuing gold(I) 
species FOH would return the Au(I) catalyst and 
DDQH2. Subsequent electrophilic ring-opening of IIa 
by either of these two possible routes might furnish the 
carbocationic species IIIa. Aromatization of this 
Wheland-type intermediate would then deliver the 3,5-
disubstituted phenolic product 4a. 
Conclusion 
In summary, we have developed a strategy for the 
assembly of a wide variety of 3,5-disubstituted phenol 
derivatives from gold(I)-catalyzed dehydrogenative 
cycloisomerization of 1,4-enyne esters in the presence 
of DDQ or NFSI. The utility of the present method was 
demonstrated by the scale-up conversion of one 
example followed by its transformation to the 
corresponding 3,5-disubstituted phenols with a range 
of functionalities, which are ubiquitous building 
blocks in a myriad of bioactive compounds.[2–5] The 
synthetic application of this approach was also 
exemplified by modifying one adduct obtained to the 
biologically active molecule LUF5771, a potent 
allosteric inhibitor of the human luteinizing hormone 
receptor.[2] Further exploration of the synthetic 
applications of the present reaction are currently 
underway and will be reported in due course. 
Experimental Section 
Representative Experimental Procedure for Gold(I) 
Complex A Catalyzed Dehydrogenative 
Cycloisomerization of 1,4-Enyne Esters (Method A with 
DDQ as the Oxidant):  
To a solution of 1,4-enyne ester 1 (0.3 mmol) and DDQ 
(0.36 mmol) in 1,2-dichloroethane (6 mL) was added 
gold(I) catalyst A (6 μmol) under an argon atmosphere. The 
reaction mixture was stirred at 80 °C for 4 h. Upon 
completion, the reaction mixture was cooled to room 
temperature and filtered through Celite, washed with 
CH2Cl2 (10 mL) and the solvent was removed under reduced 
pressure. Purification by flash column chromatography on 
silica gel (petroleum ether:EtOAc:CH2Cl2 = 50:1:1 as eluent) 
to give the title compound.  
Representative Experimental Procedure for Gold(I) 
Complex A Catalyzed Dehydrogenative 
Cycloisomerization of 1,4-Enyne Esters (Method B with 







































































































To a solution of 1,4-enyne ester 1 (0.3 mmol) and NFSI (0.6 
mmol) in 1,2-dichloroethane (6 mL) was added gold(I) 
catalyst A (6 μmol) under an argon atmosphere. The 
reaction mixture was stirred at 80 °C for 12 h. Upon 
completion, the reaction mixture was cooled to room 
temperature and the solvent was removed under reduced 
pressure. Purification by flash column chromatography on 
silica gel (petroleum ether:EtOAc:CH2Cl2 = 50:1:1 as 
eluent) to give title compound. 
5-methyl-[1,1'-biphenyl]-3-yl 4-nitrobenzoate (4a):  
Yield: 99 mg, 99% (Method A). Colorless solid; mp 101-
103 °C. 1H NMR (CDCl3, 400 MHz): δ 2.50 (s, 3H), 7.07 (s, 
1H), 7.29 (d, 1H, J = 1.9 Hz), 7.38-7.42 (m, 2H), 7.46-7.49 
(m, 2H), 7.62-7.64 (m, 2H), 8.37-8.44 (m, 4H). 13C NMR 
(CDCl3, 100 MHz): δ 21.6, 117.3, 120.8, 123.8, 126.1, 
127.2, 127.8, 128.9, 131.3, 135.0, 140.1, 140.2, 142.9, 150.8, 
150.9, 163.5. IR (KBr) ν: 3109, 1735, 1528, 1266, 1085, 713 
cm-1. HRMS (ESI) calcd for C20H15NO4Na [M+Na]+: 
356.0899, found: 356.0894. 
5-methyl-[1,1'-biphenyl]-3-yl acetate (4b): 
Yield: 50.2 mg, 74% (Method A). Pale-yellow oil. 1H NMR 
(CDCl3, 400 MHz): δ 2.33 (s, 3H), 2.43 (s, 3H), 6.91 (s, 1H), 
7.12 (s, 1H), 7.29 (s, 1H), 7.35 (t, 1H, J = 7.3 Hz), 7.43 (t, 
2H, J = 7.5 Hz), 7.57 (d, 2H, J = 7.6 Hz). 13C NMR (CDCl3, 
100 MHz): δ 21.2, 21.5, 117.5, 121.0, 125.6, 127.2, 127.6, 
128.8, 139.9, 140.4, 142.6, 151.0, 169.6. IR (neat) ν: 3034, 
2921, 1769, 1614, 1208, 1019, 762 cm-1. HRMS (ESI) calcd 
for C15H15O2 [M+H]+: 227.1072, found: 227.1077. 
5-(phenoxymethyl)-[1,1'-biphenyl]-3-yl 4-nitrobenzoate 
(4c): 
Yield: 92 mg, 72% (Method A). Yellow solid; mp 80-82 °C. 
1H NMR (CDCl3, 600 MHz): δ 5.18 (s, 2H), 7.01 (dt, 3H, J 
= 15.1, 4.1 Hz), 7.28-7.37 (m, 3H), 7.40 (m, 1H), 7.42-7.50 
(m, 3H), 7.62 (dd, 3H, J = 5.6, 3.8 Hz), 8.34-8.45 (m, 4H). 
13C NMR (CDCl3, 150 MHz): δ 69.3, 114.9, 119.0, 119.7, 
121.3, 123.8, 123.9, 127.3, 128.0, 128.9, 129.6, 131.4, 134.9, 
139.7, 139.8, 143.4, 151.0, 151.2, 158.6, 163.3. IR (KBr) ν: 
3461, 3112, 1742, 1518, 1259, 1078, 715 cm-1. HRMS (ESI) 




Yield: 54 mg, 46% (Method B). Pale-yellow oil. 1H NMR 
(CDCl3, 400 MHz): δ 2.14 (s, 3H), 5.21 (s, 2H), 7.24 (s, 1H), 
7.35-7.49 (m, 4H), 7.53 (s, 1H), 7.56-7.64 (m, 2H), 8.33-
8.45 (m, 4H). 13C NMR (CDCl3, 100 MHz): δ 21.0, 65.6, 
119.8, 120.0, 123.8, 124.9, 127.2, 128.1, 129.0, 131.4, 134.8, 
138.3, 139.6, 143.5, 151.0, 163.3, 170.8. IR (neat) ν: 3460, 
3113, 1742, 1526, 1262, 1081, 716, 544 cm-1. HRMS (ESI) 
calcd for C22H17NO6Na [M+Na]+: 414.0954, found: 
414.0959.   
2-methyl-2-((5-((4-nitrobenzoyl)oxy)-[1,1'-biphenyl]-3-
yl)methyl)malonate (4e): 
Yield: 110.7 mg, 73% (Method A). Colorless solid; mp 75-
76 °C. 1H NMR (CDCl3, 600 MHz): δ 1.25 (t, J = 7.1 Hz, 
6H), 1.43 (s, 3H), 3.33 (s, 2H), 4.21 (q, 4H, J = 7.1 Hz), 7.04 
(s, 1H), 7.31 (s, 1H), 7.32 (s, 1H),7.37 (t, 1H, J = 7.4 Hz), 
7.44 (t, 2H, J = 7.6 Hz), 7.52-7.60 (m, 2H), 8.32-8.44 (m, 
4H). 13C NMR (CDCl3, 150 MHz): δ 14.0, 20.0, 41.1, 54.9, 
61.5, 118.7, 122.0, 123.8, 127.2, 127.9, 128.9, 131.3, 135.0, 
142.8, 150.7, 151.0, 163.2, 171.8. IR (KBr) ν: 3413, 
3116,1736, 1613, 1524, 1267, 1097, 711 cm-1. HRMS (ESI) 
calcd for C28H28NO8 [M+H]+: 506.1815, found: 506.1822.  
5-(((4-methyl-N-phenylphenyl)sulfonamido)methyl)-
[1,1'-biphenyl]-3-yl acetate (4f): 
Yield: 137.2 mg, 97% (Method A). Pale-yellow oil. 1H 
NMR (CDCl3, 600 MHz): δ 2.29 (s, 3H), 2.44 (s, 3H), 4.78 
(s, 2H), 7.00-7.05 (m, 3H), 7.15 (t, 1H, J = 1.8 Hz), 7.22-
7.25 (m, 3H), 7.28 (d, 3H, J = 1.4 Hz), 7.32-7.34 (m, 1H), 
7.40 (t, 2H, J = 7.3 Hz), 7.42-7.46 (m, 2H), 7.56 (d, 2H, J = 
8.2 Hz). 13C NMR (CDCl3, 150 MHz): δ 21.2, 21.6, 54.6, 
119.6, 120.5, 124.6, 127.1, 127.8, 128.1, 128.8, 129.0, 129.1, 
129.6, 135.5, 138.2, 139.0, 139.7, 142.7, 143.7, 151.1, 169.5. 
IR (neat) ν: 3131, 1766, 1595, 1400, 1206, 1163, 696 cm-1. 
HRMS (ESI) calcd for C28H25NO4SNa [M+Na]+: 494.1402, 
found: 494.1402. 
4',5-dimethyl-[1,1'-biphenyl]-3-yl 4-nitrobenzoate (4g): 
Yield: 102 mg, 98% (Method A). Pale-yellow solid; mp 
124-126 °C. 1H NMR (CDCl3, 600 MHz): δ 2.43 (s, 3H), 
2.49 (s, 3H), 7.04 (s, 1H), 7.28 (d, 3H, J = 8.4 Hz,), 7.37 (s, 
1H), 7.52 (d, 2H, J = 8.1 Hz), 8.37-8.43 (m, 4H). 13C NMR 
(CDCl3, 150 MHz): δ 21.1, 21.5, 117.0, 120.5, 123.7, 125.9, 
127.0, 129.6, 131.3, 135.1, 137.2, 137.6, 140.1, 142.8, 150.9, 
150.9, 163.5. IR (KBr) ν: 3458, 3117, 1739, 1523, 1349, 
1262, 1085, 711 cm-1. HRMS (ESI) calcd for C21H17NO4Na 
[M+Na]+: 370.1055, found: 370.1049.  
4'-bromo-5-methyl-[1,1'-biphenyl]-3-yl 4-nitrobenzoate 
(4h):  
Yield: 108.7 mg, 96% (Method A). Colorless solid; mp 105-
107 °C. 1H NMR (CDCl3, 600 MHz): δ 2.47 (s, 3H), 7.06 (s, 
1H), 7.22 (t, 1H, J = 1.5 Hz), 7.31 (d, 1H, J = 0.5 Hz), 7.42-
7.48 (m, 2H), 7.52-7.60 (m, 2H), 8.32-8.42 (m, 4H). 13C 
NMR (CDCl3, 150 MHz): δ 21.5, 117.1, 121.2, 122.1, 123.8, 
125.8, 128.8, 131.3, 132.0, 134.9, 139.0, 140.5, 141.6, 151.0, 
163.4. IR (KBr) ν: 3450, 3166, 1736, 1527, 1265, 1091, 806, 
712 cm-1. HRMS (ESI) calcd for C20H14NO479BrNa 
[M+Na]+: 434.0004, found: 434.0007.   
5-methyl-[1,1':4',1''-terphenyl]-3-yl 4-nitrobenzoate (4i): 
Yield: 111.8 mg, 91% (Method A). Yellow solid; mp 168-
171 °C. 1H NMR (CDCl3, 400 MHz): δ 2.49 (s, 3H), 7.06 (s, 
1H), 7.31 (s, 1H), 7.34-7.40 (m, 1H), 7.42 (s, 1H), 7.47 (t, J 
= 7.6 Hz, 2H), 7.61-7.72 (m, 6H), 8.34-8.44 (m, 4H). 13C 
NMR (CDCl3, 100 MHz): δ 21.6, 117.1, 120.9, 123.8, 125.9, 
127.1, 127.5, 127.6, 128.9, 131.3, 135.0, 139.0, 140.3, 140.5, 
140.6, 142.4, 150.9, 163.5. IR (KBr) ν: 3116, 1729, 1525, 
1261, 840, 712 cm-1. HRMS (ESI) calcd for C26H20NO4 
[M+H]+: 410.1392, found: 410.1392.  
2'-bromo-5-methyl-[1,1'-biphenyl]-3-yl 4-nitrobenzoate 
(4j):  
Yield: 113.8 mg, 92% (Method A). Colorless solid; mp 126-
128 °C. 1H NMR (CDCl3, 600 MHz): δ 2.47 (s, 3H), 7.06 (s, 
1H), 7.22 (t, 1H, J = 1.5 Hz), 7.31 (d, 1H, J = 0.5 Hz), 7.42-
7.48 (m, 2H), 7.52-7.60 (m, 2H),8.32-8.42 (m, 4H). 13C 
NMR (CDCl3, 150 MHz): δ 21.5, 117.1, 121.2, 122.1, 123.8, 
125.8, 128.8, 131.3, 132.0, 134.9, 139.0, 140.5, 141.6, 151.0, 
163.4. IR (KBr) ν: 3449, 3166, 1736, 1527, 1336, 1265, 
1092, 712 cm-1. HRMS (ESI) calcd for C20H14NO479BrNa 
[M+Na]+: 434.0004, found: 434.0011.   
2'-iodo-5-methyl-[1,1'-biphenyl]-3-yl 4-nitrobenzoate 
(4k): 
Yield: 120 mg, 87% (Method A). Colorless solid; mp 156-
159 °C. 1H NMR (CDCl3, 600 MHz): δ 2.46 (s, 3H), 7.02-
7.07 (m, 2H), 7.10 (s, 2H), 7.33 (dd, 1H, J = 7.6, 1.5 Hz), 
7.39 (t, 1H, J = 7.5 Hz), 7.95 (d, 1H, J = 7.9 Hz), 8.37 (q, J 
= 8.9 Hz, 4H). 13C NMR (CDCl3, 150 MHz): δ 21.4, 98.2, 
119.6, 121.2, 123.8, 128.2, 128.2, 129.1, 130.1, 131.3, 135.0, 
139.6, 145.5, 145.5, 149.9, 150.9, 163.3. IR (KBr) ν: 3421, 
3130, 1743, 1522, 1256, 1077, 764, 713 cm-1. HRMS (ESI) 





Yield: 115 mg, 84% (Method A). Colorless solid; mp 150-
152 °C. 1H NMR (CDCl3, 400 MHz): δ 2.44 (s, 3H), 6.02 (s, 
2H), 6.83 (s, 1H), 7.06 (d, 2H, J = 0.7 Hz), 7.07-7.13 (m, 
2H), 8.31-8.42 (m, 4H). 13C NMR (CDCl3, 100 MHz): δ 
21.4, 102.0, 110.8, 113.0, 113.0, 119.8, 121.1, 123.7, 128.4, 
131.3, 134.7, 135.0, 139.6, 142.4, 147.4, 147.9, 150.0, 150.9, 
163.3. IR (KBr) ν: 3109, 1743, 1519, 1260, 1233, 1081, 869, 
716 cm-1. HRMS (ESI) calcd for C21H15NO679Br [M+H]+: 
456.0083, found: 456.0088.   
2'-bromo-4',5'-dimethoxy-5-methyl-[1,1'-biphenyl]-3-yl 
4-nitrobenzoate (4m): 
Yield: 120 mg, 85% (Method A). Colorless solid; mp 183-
185 °C. 1H NMR (CDCl3, 400 MHz): δ 2.46 (s, 3H), 3.88 (s, 
3H), 3.91 (s, 3H), 6.85 (s, 1H), 7.06 (s, 1H), 7.09 (s, 1H), 
7.11 (s, 1H), 7.15 (d, 1H, J = 0.6 Hz), 8.33-8.41 (m, 4H). 
13C NMR (CDCl3, 100 MHz): δ 21.5, 56.2, 56.3, 112.4, 
113.8, 115.8, 119.8, 121.0, 123.7, 128.4, 131.3, 133.6, 135.0, 
139.6, 142.5, 148.3, 149.0, 150.0, 150.9, 163.4. IR (KBr) ν: 
3413, 3109, 1741, 1524, 1248, 1139, 714 cm-1. HRMS (ESI) 
calcd for C22H19NO679Br [M+H]+: 472.0396, found: 
472.0393.   
3-methyl-5-(naphthalen-1-yl)phenyl 4-nitrobenzoate 
(4n): 
Yield: 113.9 mg, 99% (Method A). Pale-yellow oil. 1H 
NMR (CDCl3, 600 MHz): δ 2.50 (s, 3H), 7.14 (s, 1H), 7.19 
(s, 1H), 7.28 (s, 1H), 7.43-7.55 (m, 4H), 7.88 (d, 1H, J = 8.2 
Hz), 7.91 (d, 1H, J = 7.7 Hz), 7.96 (d, 1H, J = 8.3 Hz), 8.32-
8.37 (m, 2H), 8.37-8.42 (m, 2H). 13C NMR (CDCl3, 150 
MHz): δ 21.5, 120.2, 120.9, 123.7, 125.3, 125.8, 125.9, 
126.3, 127.0, 128.1, 128.4, 129.0, 131.3, 131.4, 133.8, 135.0, 
139.1, 139.8, 142.3, 150.4, 150.9, 163.4; IR (neat) ν: 3114, 
1741, 1526, 1397, 1263, 1082, 778, 714 cm-1. HRMS (ESI) 




Yield: 104.7 mg, 91% (Method A). Pale-yellow solid; mp 
154-156 °C. 1H NMR (CDCl3, 600 MHz): δ 2.51 (s, 3H), 
7.08 (s, 1H), 7.40 (s, 1H), 7.47-7.55 (m, 3H), 7.74 (dd, 1H, 
J = 8.5, 1.8 Hz), 7.85-7.95 (m, 3H), 8.06 (d, 1H, J = 1.1 Hz), 
8.32-8.44 (m, 4H). 13C NMR (CDCl3, 150 MHz): δ 21.6, 
117.5, 120.9, 123.8, 125.4, 126.0, 126.2, 126.3, 126.5, 127.7, 
128.3, 128.6, 131.3, 132.8, 133.6, 135.0, 137.4, 140.3, 142.8, 
150.9, 151.0, 163.5. IR (KBr) ν: 3125, 1741, 1523, 1256, 
1080, 713 cm-1. HRMS (ESI) calcd for C24H17NO4Na 
[M+Na]+: 406.1055, found: 406.1057.   
3-methyl-5-(1-tosyl-1H-indol-3-yl)phenyl 4-
nitrobenzoate (4p): 
Yield: 98 mg, 62% (Method A). Pale-yellow solid; mp 129-
131 °C. 1H NMR (CDCl3, 400 MHz): δ 2.34 (s, 3H), 2.47 (s, 
3H), 7.06 (s, 1H), 7.18-7.41 (m, 6H), 7.73 (s, 1H), 7.80 (t, 
3H, J = 7.6 Hz), 8.06 (d, 1H, J = 8.2 Hz), 8.28-8.46 (m, 4H). 
13C NMR (CDCl3, 100 MHz): δ 21.5, 21.6, 113.9, 117.9, 
120.3, 121.1, 122.9, 123.4, 123.7, 123.8, 125.1, 126.7, 126.9, 
129.0, 130.0, 131.3, 134.6, 134.9, 135.1, 135.5, 140.5, 145.2, 
150.9, 163.5. IR (KBr) ν: 3123, 1740, 1524, 1374, 1264, 
1175, 682, 577 cm-1. HRMS (ESI) calcd for C29H22N2O6SNa 
[M+Na]+: 549.1096, found: 549.1087.   
[1,1':3',1''-terphenyl]-5'-yl 4-nitrobenzoate (4q): 
Yield: 80.7 mg, 68% (Method B). Pale-yellow solid; mp 
133-135 °C. 1H NMR (CDCl3, 400 MHz): δ 7.37-7.53 (m, 
8H), 7.62-7.71 (m, 4H), 7.77 (t, 1H, J = 1.5 Hz), 8.34-8.48 
(m, 4H). 13C NMR (CDCl3, 100 MHz): δ 118.9, 123.8, 124.1, 
127.3, 128.0, 129.0, 131.4, 134.9, 140.0, 143.5, 151.0, 151.3, 
163.4. IR (KBr) ν: 3108, 1744, 1521, 1258, 1082, 756 cm-1. 
HRMS (ESI) calcd for C25H17NO4Na [M+Na]+: 418.1055, 
found: 418.1055.   
3-cyclopropyl-5-methylphenyl 4-nitrobenzoate (4r): 
Yield: 68.7 mg, 77% (Method A). Colorless solid; mp 77-
79 °C. 1H NMR (CDCl3, 600 MHz): δ 0.64-0.77 (m, 2H), 
0.96-1.00 (m, 2H), 1.87-1.92 (m, 1H), 2.35 (s, 3H), 6.71 (s, 
1H), 6.83 (d, 2H, J = 11.4 Hz), 8.28-8.41 (m, 4H). 13C NMR 
(CDCl3, 100 MHz): δ 9.4, 15.3, 21.4, 115.6, 119.0, 123.7, 
124.8, 131.2, 135.2, 139.6, 146.1, 150.6, 150.9, 163.5. IR 
(KBr) ν: 3110, 1737, 1519, 1268, 1089, 715 cm-1. HRMS 
(ESI) calcd for C17H15NO4Na [M+Na]+: 320.0899, found: 
320.0891.   
3-cyclopentyl-5-methylphenyl 4-nitrobenzoate (4s): 
Yield: 58.6 mg, 60% (Method B). Colorless solid; mp 103-
105 °C. 1H NMR (CDCl3, 400 MHz): δ 1.89-1.54 (m, 6H), 
2.02-2.13 (m, 2H), 2.37 (s, 3H), 2.92-3.06 (m, 1H), 6.86 (s, 
1H), 6.89 (s, 1H), 7.00 (s, 1H), 8.31-8.42 (m, 4H).13C NMR 
(CDCl3, 100 MHz): δ 21.4, 25.5, 34.5, 45.7, 116.9, 119.2, 
123.7, 126.2, 131.3, 135.2, 139.5, 148.5, 150.5, 150.9, 163.5. 
IR (KBr) ν: 2924, 1745, 1521, 1263, 1087, 871, 711 cm-1.  
HRMS (ESI) calcd for C19H19NO4Na [M+Na]+: 348.1212, 
found: 348.1215.  
3-cyclohexyl-5-methylphenyl 4-nitrobenzoate (4t): 
Yield: 62.1 mg, 61% (Method B). Colorless solid; mp 97-
99 °C. 1H NMR (CDCl3, 600 MHz): δ 1.18-1.32 (m, 2H), 
1.32-1.46 (m, 4H), 1.70-1.78 (m, 1H), 1.80-1.94 (m, 4H), 
2.38 (s, 3H), 2.48-2.53 (m, 1H), 6.87 (d, 2H, J = 2.0 Hz), 
6.97 (s, 1H), 8.29-8.42 (m, 4H). 13C NMR (CDCl3, 100 
MHz): δ 21.4, 26.1, 26.8, 34.4, 44.4, 76.7, 77.0, 77.4, 116.7, 
119.3, 123.7, 125.9, 131.2, 135.3, 139.5, 149.9, 150.5, 150.9, 
163.5. IR (KBr) ν: 3118, 2925, 1741, 1516, 1258, 1088, 712 
cm-1. HRMS (ESI) calcd for C20H22NO4 [M+H]+: 340.1549, 
found: 340.1552.  
3-methyl-5-(pentan-3-yl)phenyl 4-nitrobenzoate (4u): 
Yield: 72.7 mg, 74% (Method A). Pale-yellow solid; mp 74-
76 °C. 1H NMR (CDCl3, 600 MHz): δ 0.81 (t, 6H, J = 7.4 
Hz), 1.52-1.60 (m, 2H), 1.66-1.73 (m, 2H), 2.30-2.35 (m, 
1H), 2.38 (s, 3H), 6.80 (s, 1H), 6.88 (s, 1H), 6.90 (s, 1H), 
8.33-8.41 (m, 4H). 13C NMR (CDCl3, 150 MHz): δ 12.2, 
21.5, 29.2, 49.6, 117.5, 119.3, 123.7, 126.9, 131.2, 135.3, 
139.4, 147.8, 150.5, 150.8, 163.4. IR (KBr) ν: 3115, 1733, 
1529, 1348, 1267, 712 cm-1. HRMS (ESI) calcd for 
C19H22NO4 [M+H]+: 328.1549, found: 328.1541.  
3-methyl-5-(3-phenylpropyl)phenyl 4-nitrobenzoate 
(4v): 
Yield: 72.1 mg, 64% (Method A). Pale-yellow solid; mp 53-
55 °C. 1H NMR (CDCl3, 400 MHz): δ 1.92-2.08 (m, 2H), 
2.69 (q, 4H, J =14.6 Hz), 6.90 (d, 2H, J = 5.2 Hz), 6.98 (s, 
1H), 7.16-7.38 (m, 5H), 8.31-8.46 (m, 4H). 13C NMR 
(CDCl3, 100 MHz): δ 21.4, 32.7, 35.2, 35.5, 118.3, 119.4, 
123.7, 125.9, 127.5, 128.4, 128.5, 131.3, 135.2, 139.7, 142.1, 
144.1, 150.6, 150.9, 163.5. IR (KBr) ν: 2932, 1731, 1522, 
1264, 1087, 869, 714 cm-1. HRMS (ESI) calcd for 
C23H21NO4Na [M+Na]+: 398.1368, found: 398.1372.  
3-hexyl-5-methylphenyl 4-nitrobenzoate (4w): 
Yield: 61.5 mg, 60% (Method B). Pale-yellow oil. 1H NMR 
(CDCl3, 400 MHz): δ 0.89 (t, 3H, J = 6.7 Hz), 1.25-1.41 (m, 
6H), 1.56-1.68 (m, 2H), 2.37 (s, 3H), 2.56-2.66 (m, 2H), 
6.86 (d, 2H, J = 4.1 Hz), 6.95 (s, 1H), 8.32-8.40 (m, 4H). 
13C NMR (CDCl3, 100 MHz): δ 14.1, 21.4, 22.6, 29.0, 31.2, 
31.7, 35.8, 118.2, 119.1, 123.7, 127.4, 131.2, 135.2, 139.5, 
144.8, 150.5, 150.8, 163.5. IR (neat) ν: 3121, 2926, 1744, 
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1529, 1259, 1140, 712 cm-1. HRMS (ESI) calcd for 
C20H23NO4Na [M+Na]+: 364.1525, found: 364.1525.  
5,5''-dimethyl-[1,1':4',1''-terphenyl]-3,3''-diyl diacetate 
(4x): 
Yield: 59.5 mg, 53% (Method A). Pale-yellow solid; mp 
174-176 °C. 1H NMR (CDCl3, 600 MHz): δ 2.33 (s, 6H), 
2.44 (s, 6H), 6.92 (s, 2H), 7.16 (s, 2H), 7.32 (s, 2H), 7.63 (s, 
4H). 13C NMR (CDCl3, 150 MHz): δ 21.2, 21.5, 117.3, 
121.2, 125.4, 127.5, 139.5, 140.0, 142.0, 151.1, 169.7. IR 
(KBr) ν: 3128, 1752, 1587, 1399, 1216, 1144, 841 cm-1. 
HRMS (ESI) calcd for C24H22O4Na [M+Na]+: 397.1416, 




cyclopenta[a]chrysen-3a-yl)methyl acetate (4y): 
Yield: 196.5 mg, 94% (Method A). Pale-yellow solid; mp 
161-163 °C. 1H NMR (CDCl3, 400 MHz): δ 0.52-0.67 (m, 
1H), 0.67-0.92 (m, 10H), 0.93 (s, 3H), 0.99-1.29 (m, 9H), 
1.29-1.46 (m, 6H), 1.47-1.83 (m, 6H), 1.86-1.95 (m, 3H), 
2.03 (s, 3H), 2.10 (s, 3H), 2.32 (s, 4H), 2.87-2.94 (m, 1H), 
3.95 (d, 1H, J = 11.0 Hz), 4.32 (d, 1H, J = 10.9 Hz), 4.42 (t, 
1H, J = 7.6 Hz), 6.90 (s, 1H), 7.11 (t, 1H, J = 1.8 Hz), 7.27 
(s, 1H), 7.33-7.37 (m, 1H), 7.43 (t, 2H, J = 7.5 Hz), 7.51-
7.61 (m, 2H). 13C NMR (CDCl3, 100 MHz): δ 14.7, 16.0, 
16.1, 18.2, 20.8, 21.1, 21.3, 21.3, 23.7, 27.0, 27.1, 28.0, 29.8, 
34.1, 34.2, 34.8, 37.0, 37.5, 37.8, 38.3, 40.8, 42.6, 46.5, 46.7, 
49.9, 54.2, 55.3, 62.8, 80.9, 117.6, 127.2, 127.6, 128.8, 
140.5, 142.5, 150.9, 151.1, 169.4, 171.0, 171.6. IR (KBr) ν: 
2948, 1769, 1735, 1455, 1366, 1243, 1029, 763, 701 cm-1. 
HRMS (ESI) calcd for C45H61O6 [M+H]+: 697.4468, found: 
697.4464.  
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